论文信息 - Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial - 字舞流文

Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial

S. Choi | Joon-Oh Park | D. Yoon | Jin‐Young Jang | J. Lee | Youngmin Han | W. Kwon | Sun-Whe Kim | J. Heo | D. Lim | Joon Seong Park | D. Oh | E. Chie | Sang Jae Park | Kyung-Hun Lee | Woojin Lee | Y. Koh | Seong Hyun Kim | I. Lee | Hongeun Lee